4o91: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
''' | ==Crystal Structure of type II inhibitor NG25 bound to TAK1-TAB1== | ||
<StructureSection load='4o91' size='340' side='right' caption='[[4o91]], [[Resolution|resolution]] 2.39Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[4o91]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4O91 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4O91 FirstGlance]. <br> | |||
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NG2:N-{4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}-4-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-4-YLOXY)BENZAMIDE'>NG2</scene><br> | |||
<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Mitogen-activated_protein_kinase_kinase_kinase Mitogen-activated protein kinase kinase kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.25 2.7.11.25] </span></td></tr> | |||
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4o91 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4o91 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4o91 RCSB], [http://www.ebi.ac.uk/pdbsum/4o91 PDBsum]</span></td></tr> | |||
<table> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Mitogen-activated protein kinase kinase kinase]] | |||
[[Category: Gurbani, D.]] | |||
[[Category: Hunter, J C.]] | |||
[[Category: Tan, L.]] | |||
[[Category: Westover, K D.]] | |||
[[Category: Mitogen-activated protein kinase kinase kinase 7]] | |||
[[Category: Serine/threonine kinase which acts as an essential component of the map kinase signal transduction pathway]] | |||
[[Category: Tgf-beta-activated kinase 1 and map3k7-binding protein 1]] | |||
[[Category: Tgf-beta-activated kinase 1 and map3k7-binding protein 1 chimera]] | |||
[[Category: Transferase-transferase inhibitor complex]] | |||